CI-generated notebook stub for analysis sda-2026-04-01-gap-20260401-225149. What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesis through the gut-brain

analysis auto ci

📊 What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesis through the gut-brain axis? (neurodegeneration)

Created: 2026-04-16

View Notebook →

Why does prolonged anesthesia cause both cognitive dysfunction and anxiety through the same synaptic mechanism? — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-08-gap-pubmed-20260406-062128-34a47c4e. The study reports that complement-mediated synaptic elimination produces both cognitive deficits and anxiety

analysis auto ci

📊 Why does prolonged anesthesia cause both cognitive dysfunction and anxiety through the same synaptic mechanism? (neurodegeneration)

Created: 2026-04-16

What determines the selectivity and efficiency of intercellular transmission pathways for different misfolded proteins? — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-08-gap-pubmed-20260406-062207-5a703c17. While the abstract establishes that intercellular transmission occurs for various proteins (tau, α-synuclein

analysis auto ci

📊 What determines the selectivity and efficiency of intercellular transmission pathways for different misfolded proteins? (neurodegeneration)

Created: 2026-04-16

Lipid metabolism dysregulation and membrane integrity in Alzheimer disease — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-04-frontier-lipidomics-dcdbc360. How do alterations in brain lipid metabolism—including gangliosides, phospholipids, cholesterol transport, and sphi

analysis auto ci

📊 Lipid metabolism dysregulation and membrane integrity in Alzheimer disease (neurodegeneration)

Created: 2026-04-16

View Notebook →

CI-generated notebook stub for analysis SDA-2026-04-15-gap-debate-20260410-112539-31f47880. The debate assumed static 5-hydroxymethylcytosine patterns in aging neurons are harmful, but the skeptic rai

analysis auto ci

Created: 2026-04-16

What are the precise temporal dynamics of astrocyte ketone production decline during neurodegeneration progression? — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-15-gap-debate-20260410-112330-9abf86eb. The debate identified a critical therapeutic window when astrocytic ketone production declines but neurons r

stub auto ci

📊 What are the precise temporal dynamics of astrocyte ketone production decline during neurodegeneration progression? (neurodegeneration)

Created: 2026-04-16

View Notebook →

What are the specific molecular determinants that govern tau strain selection during prion-like propagation? — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-15-gap-debate-20260410-112730-24052bbe. The debate highlighted tau prion-like transmission but did not resolve how different tau conformations compe

stub auto ci

📊 What are the specific molecular determinants that govern tau strain selection during prion-like propagation? (neurodegeneration)

Created: 2026-04-16

View Notebook →

Do bacterial curli amyloids cross the blood-brain barrier to directly seed α-synuclein aggregation in humans? — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-12-gap-debate-20260410-112927-b4535f82. Do bacterial curli amyloids cross the blood-brain barrier to directly seed α-synuclein aggregation in humans

analysis auto ci

📊 Do bacterial curli amyloids cross the blood-brain barrier to directly seed α-synuclein aggregation in humans? (neurodegeneration)

Created: 2026-04-16

CI-generated notebook stub for analysis SDA-2026-04-08-gap-pubmed-20260406-062207-b800e5d3. The abstract acknowledges that host cells influence seed properties, but the specific cellular factors and m

analysis auto ci

📊 How do host cell factors influence the conformation and propagation properties of transmitted pathological seeds? (neurodegeneration)

Created: 2026-04-16

Do different priming stimuli require distinct therapeutic approaches or share common epigenetic pathways? — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-08-gap-debate-20260406-062039-f02efa4b. The skeptic proposed that epigenetic modifiers should work equally well regardless of initial priming stimul

analysis auto ci

📊 Do different priming stimuli require distinct therapeutic approaches or share common epigenetic pathways? (immunology)

Created: 2026-04-16

Gut-Brain Axis Therapeutics for AD — Analysis Notebook

CI-generated notebook stub for analysis sda-2026-04-01-003. Can gut-brain axis modulation prevent or slow Alzheimer's disease pathology?

CI-generated notebook stub for analysis SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47. While the abstract mentions identifying subcellular roles of protein interactions, the mechanistic principle

analysis auto ci

📊 How do protein-protein interactions determine subcellular localization and function specificity? (synaptic biology)

Created: 2026-04-16

Is APOE4's reduced lipid binding pathogenic or a compensatory evolutionary adaptation? — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-16-gap-debate-20260410-113104-a13caf2e. The skeptic raised evidence that APOE4 carriers show enhanced cholesterol synthesis, suggesting the lipid bi

stub auto ci

📊 Is APOE4's reduced lipid binding pathogenic or a compensatory evolutionary adaptation? (molecular biology)

Created: 2026-04-16

View Notebook →

What determines the GPX4/ACSL4 balance that switches microglia from protective to ferroptotic states? — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-15-gap-debate-20260410-112528-782f5aa2. While ACSL4-driven ferroptosis was strongly supported, the molecular triggers that tip the balance from prot

analysis auto ci

📊 What determines the GPX4/ACSL4 balance that switches microglia from protective to ferroptotic states? (immunology)

Created: 2026-04-16

Extracellular vesicle biomarkers for early AD detection — Analysis Notebook

CI-generated notebook stub for analysis sda-2026-04-12-ev-ad-biomarkers. Which EV-derived biomarkers (phospho-tau, amyloid-beta, synaptic proteins, inflammatory mediators) show the highest diagnostic

analysis auto ci

📊 Extracellular vesicle biomarkers for early AD detection (neurodegeneration)

Created: 2026-04-16

View Notebook →

Why do systemic anti-inflammatory drugs fail in AD despite cardiovascular efficacy if neuroinflammation is central? — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-08-gap-debate-20260406-062045-ce866189. The debate noted clinical failures of TNF-α and IL-6 inhibitors in AD despite their cardiovascular success a

analysis auto ci

📊 Why do systemic anti-inflammatory drugs fail in AD despite cardiovascular efficacy if neuroinflammation is central? (clinical neurology)

Created: 2026-04-16

How do disease-associated mutations in G3BP1 or its binding partners alter stress granule dynamics? — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-06-gap-pubmed-20260406-041428-e14e6524. The study establishes G3BP1's role as a tunable switch for stress granule assembly, but doesn't address how

draft auto ci

📊 How do disease-associated mutations in G3BP1 or its binding partners alter stress granule dynamics? (neurodegeneration)

Created: 2026-04-06

Unable to extract research questions - transcript appears to be empty — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-04-gap-debate-20260403-222510-20260402. The provided transcript contains only speaker labels [Theorist] and [Synthesizer] with no actual debate cont

stub auto ci

📊 Unable to extract research questions - transcript appears to be empty (methodology)

Created: 2026-04-06

View Notebook →

Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-03-gap-aging-mouse-brain-20260402. What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mo

analysis auto ci

📊 Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability (neurodegeneration)

Created: 2026-04-06

View Notebook →

SEA-AD Single-Cell Analysis: Cell-Type Vulnerability in Alzheimer's Disease — Analysis Notebook

CI-generated notebook stub for analysis analysis_sea_ad_001. What are the cell-type specific vulnerability mechanisms in Alzheimer's disease based on SEA-AD single-cell data?

Notebook Artifact Registry

🌟 Spotlight Notebooks

Gene Expression Changes in Aging Mouse Brain Predicting Neurodegenerative Vulnerability

Neuroinflammation and Microglial Priming in Early Alzheimer's Disease

CRISPR-Based Therapeutic Approaches for Neurodegenerative Diseases

Mitochondrial Dysfunction as a Driver of Neurodegeneration

Tau Pathology Propagation in Tauopathies — Mechanistic Dissection

All Notebooks (147) (filtered by: ci)

Investigate mechanisms of epigenetic reprogramming in aging neurons — Analysis Notebook

Does Alectinib truly bind C1q directly with high affinity, or is this an experimental artifact? — Analysis Notebook

Investigate mechanisms of epigenetic reprogramming in aging neurons, including DNA methylation changes, histone modification dynamics, chromatin remodeling, and partial reprogramming approaches (e.g., — Analysis Notebook

Investigate mechanisms of epigenetic reprogramming in aging neurons — Analysis Notebook

Neuroinflammation Biomarker Panel for Early AD Detection — Analysis Notebook

Is ferroptosis the primary driver of motor neuron death in ALS or an epiphenomenon of terminal cellular collapse? — Analysis Notebook

Multi-modal Biomarker Panel Design for Early AD Detection — Analysis Notebook

Spatial Transcriptomics Analysis of Alzheimer's Disease Brain Regions — Analysis Notebook

scRNA-seq Processing and Cell Type Annotation of AD Brain — Analysis Notebook

Do β-amyloid plaques and neurofibrillary tangles cause or result from cholinergic dysfunction? — Analysis Notebook

Clinical Trial Landscaping for Alzheimer's Disease Therapeutics — Analysis Notebook

Variant Annotation and Prioritization of AD Risk Loci — Analysis Notebook

Cell-Cell Communication Analysis in AD Brain Microenvironment — Analysis Notebook

Cas13 gRNA Design for Silencing MAPT (Tau) Transcripts in Alzheimer's Disease — Analysis Notebook

Which metabolic biomarkers can distinguish therapeutic response from disease progression in neurodegeneration trials? — Analysis Notebook

De Novo Binder Design Targeting Alpha-Synuclein Aggregation Interface — Analysis Notebook

How does Alectinib, a kinase inhibitor, achieve high-affinity binding to complement protein C1q? — Analysis Notebook

Proteomics Differential Expression in AD CSF and Brain Tissue — Analysis Notebook

Statistical Fine-Mapping of AD GWAS Loci to Identify Causal Variants — Analysis Notebook

What are the specific PTM changes in synaptic vesicle proteins during early AD pathogenesis? — Analysis Notebook

Ferroptosis in ALS and motor neuron disease: GPX4, lipid peroxidation, and iron chelation therapies — Analysis Notebook

Why do TAM receptors protect against neuroinvasive viruses despite their known immunosuppressive role? — Analysis Notebook

What molecular mechanisms enable functional recovery and muscle re-innervation after motor neuron loss in ALS/FTLD? — Analysis Notebook

Which tau PTMs are both disease-specific and druggable with selective small molecule inhibitors? — Analysis Notebook

Gene Regulatory Network Inference in Alzheimer's Disease — Analysis Notebook

Gut Microbiome Analysis in Parkinson's Disease — Analysis Notebook

How does PIKFYVE inhibition activate unconventional protein clearance via exocytosis? — Analysis Notebook

Why have anti-Aβ clinical trials failed despite the established role of Aβ in AD pathogenesis? — Analysis Notebook

Gene Co-expression Network Analysis of AD Progression Modules — Analysis Notebook

Survival Analysis of AD Patient Cohorts: Prognostic Markers and Time-to-Dementia — Analysis Notebook

Polygenic Risk Score Analysis for Late-Onset Alzheimer's Disease — Analysis Notebook

How do gut microbiome-derived metabolites SCFAs LPS TMAO influence alpha-synuclein aggregation and dopaminergic neuron survival via vagal nerve signaling in Parkinson disease — Analysis Notebook

What amyloid threshold level is required for optimal clinical benefit in early AD? — Analysis Notebook

Which metabolic biomarkers can distinguish therapeutic response from disease progression in neurodegeneration trials? - Analysis Notebook

What determines the optimal timing and dosing of ketogenic interventions for neuroprotection? - Analysis Notebook

Does LRRK2's role as a lysosomal volume sensor explain the pathogenic mechanism of disease-linked LRRK2 mutations? — Analysis Notebook

Why have numerous phase 3 clinical trials failed despite advances in understanding AD pathobiology? - Analysis Notebook

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas — Analysis Notebook

Senescent cell clearance as neurodegeneration therapy — Analysis Notebook

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines — Analysis Notebook

Microglia-astrocyte crosstalk amplification loops in neurodegeneration — Analysis Notebook

SEA-AD Single-Cell Analysis: Cell-Type Vulnerability in Alzheimer's Disease — Analysis Notebook

What are the cell-type-specific transcriptomic signatures of vulnerability in SEA-AD data? — Analysis Notebook

Synaptic pruning by microglia in early AD — Analysis Notebook

Metabolic reprogramming in neurodegenerative disease — Analysis Notebook

Epigenetic clocks and biological aging in neurodegeneration — Analysis Notebook

How does engineered C. butyricum cross the blood-brain barrier to directly bind GLP-1 receptors? — Analysis Notebook

Sleep disruption as cause and consequence of neurodegeneration — Analysis Notebook

Neuroinflammation resolution mechanisms and pro-resolving mediators — Analysis Notebook

Mitochondrial transfer between astrocytes and neurons — Analysis Notebook

Digital biomarkers and AI-driven early detection of neurodegeneration — Analysis Notebook

RNA binding protein dysregulation across ALS FTD and AD — Analysis Notebook

Perivascular spaces and glymphatic clearance failure in AD — Analysis Notebook

Neuroinflammation and microglial priming in early AD — Analysis Notebook

Which cell types show the most significant expression changes for neurodegeneration genes in SEA-AD cohorts? — Analysis Notebook

Does TFEB dysfunction cause neurodegeneration or represent a compensatory response to primary pathology? — Analysis Notebook

Circuit-level neural dynamics in neurodegeneration — Analysis Notebook

Extracellular vesicle biomarkers for early AD detection — Analysis Notebook

APOE4 structural biology and therapeutic targeting strategies — Analysis Notebook

TDP-43 phase separation therapeutics for ALS-FTD — Analysis Notebook

Mitochondrial transfer between neurons and glia — Analysis Notebook

Protein aggregation cross-seeding across neurodegenerative diseases — Analysis Notebook

Mechanistic role of APOE in neurodegeneration — Analysis Notebook

Do β-amyloid plaques and neurofibrillary tangles cause or result from cholinergic dysfunction? — Analysis Notebook

What is the actual quantitative contribution of FcRn-mediated transcytosis to BBB antibody transport in humans? — Analysis Notebook

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation and synaptic targeting? — Analysis Notebook

Should microtubule-stabilizing drugs be reconsidered as therapeutic targets for tauopathies given tau's destabilizing role? — Analysis Notebook

Senolytic therapy for age-related neurodegeneration — Analysis Notebook

Epigenetic reprogramming in aging neurons — Analysis Notebook

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data) — Analysis Notebook

What neural circuits encode and maintain multi-generational migratory route memory? — Analysis Notebook

Blood-brain barrier transport mechanisms for antibody therapeutics — Analysis Notebook